| 2nd May 2023 3:00 pm |
RNS |
Total Voting Rights |
| 28th Apr 2023 5:01 pm |
RNS |
Director/PDMR Shareholding |
| 27th Apr 2023 7:00 am |
RNS |
GSK RSV OA vaccine gains positive EMA CHMP opinion |
| 26th Apr 2023 7:00 am |
RNS |
1st Quarter Results |
| 25th Apr 2023 7:00 am |
RNS |
EMA validates Jemperli filing for new indication |
| 20th Apr 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 19th Apr 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 18th Apr 2023 7:00 am |
RNS |
GSK reaches agreement to acquire BELLUS Health Inc |
| 17th Apr 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 17th Apr 2023 7:00 am |
RNS |
Gepotidacin positive phase III data |
| 3rd Apr 2023 3:00 pm |
RNS |
Total Voting Rights |
| 28th Mar 2023 7:00 am |
RNS |
Positive phase III RUBY results for Jemperli |
| 27th Mar 2023 1:00 pm |
RNS |
Publication of 2023 AGM Notice |
| 24th Mar 2023 9:59 am |
RNS |
Statement: Zantac (ranitidine) litigation |
| 21st Mar 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 20th Mar 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 14th Mar 2023 7:05 am |
RNS |
Positive phase III results for MenABCWY vaccine |
| 14th Mar 2023 7:00 am |
RNS |
Nucala NDA accepted for review in China |
| 13th Mar 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 10th Mar 2023 4:26 pm |
RNS |
GSK Annual Report 2022 on Form 20-F |
| 10th Mar 2023 10:36 am |
RNS |
GSK publishes Annual Report 2022 |
| 2nd Mar 2023 7:00 am |
RNS |
FDA Ad Com votes to support GSK RSV OA vaccine |
| 1st Mar 2023 3:00 pm |
RNS |
Total Voting Rights |
| 27th Feb 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 23rd Feb 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 23rd Feb 2023 7:00 am |
RNS |
ViiV Healthcare announces Cabenuva positive data |
| 22nd Feb 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 16th Feb 2023 7:00 am |
RNS |
NEJM publishes GSK RSV OA vaccine candidate trial |
| 15th Feb 2023 4:04 pm |
RNS |
Director/PDMR Shareholding |
| 15th Feb 2023 4:00 pm |
RNS |
Director/PDMR Shareholding |
| 14th Feb 2023 7:00 am |
RNS |
Director/PDMR Shareholding |
| 14th Feb 2023 7:00 am |
RNS |
Director/PDMR Shareholding |
| 14th Feb 2023 7:00 am |
RNS |
Director/PDMR Shareholding |
| 14th Feb 2023 7:00 am |
RNS |
Director/PDMR Shareholding |
| 13th Feb 2023 5:35 pm |
RNS |
EMTN Notes repurchase results |
| 10th Feb 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 10th Feb 2023 7:05 am |
RNS |
Jemperli full FDA approval following GARNET trial |
| 10th Feb 2023 7:00 am |
RNS |
Jemperli FDA ODAC positive outcome |
| 2nd Feb 2023 7:00 am |
RNS |
Daprodustat approved by US FDA for anaemia of CKD |
| 1st Feb 2023 3:30 pm |
RNS |
Director/PDMR Shareholding |
